» Articles » PMID: 33572065

Investigation of Changes in Saliva in Radiotherapy-Induced Head Neck Cancer Patients

Overview
Publisher MDPI
Date 2021 Feb 12
PMID 33572065
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The intact function of the salivary glands is of utmost importance for oral health. During radiotherapy in patients with head and neck tumors, the salivary glands can be damaged, causing the composition of saliva to change. This leads to xerostomia, which is a primary contributor to oral mucositis. Medications used for protective or palliative treatment often show poor efficacy as radiation-induced changes in the physico-chemical properties of saliva are not well understood. To improve treatment options, this study aimed to carefully examine unstimulated whole saliva of patients receiving radiation therapy and compare it with healthy unstimulated whole saliva. To this end, the pH, osmolality, electrical conductivity, buffer capacity, the whole protein and mucin concentrations, and the viscoelastic and adhesive properties were investigated. Moreover, hyaluronic acid was examined as a potential candidate for a saliva replacement fluid. The results showed that the pH of radiation-induced saliva shifted from neutral to acidic, the osmolality increased and the viscoelastic properties changed due to a disruption of the mucin network and a change in water secretion from the salivary glands. By adopting an aqueous 0.25% hyaluronic acid formulation regarding the lost properties, similar adhesion characteristics as in healthy, unstimulated saliva could be achieved.

Citing Articles

Effect of different protocols in preventing demineralization in irradiated human enamel, in vitro study.

Suwannapong N, Chantarangsu S, Kamnoedboon P, Srinivasan M, Pianmee C, Bunsong C BMC Oral Health. 2025; 25(1):46.

PMID: 39780133 PMC: 11714816. DOI: 10.1186/s12903-024-05404-1.


Explorative study of stimulated saliva proteome in head and neck cancer patients pre- and post-treatment.

Almhojd U, Fisic A, Cevik-Aras H, Tuomi L, Finizia C, Almstahl A Heliyon. 2024; 10(20):e39033.

PMID: 39640734 PMC: 11620125. DOI: 10.1016/j.heliyon.2024.e39033.


Cancer therapy-related salivary dysfunction.

Paz C, Glassey A, Frick A, Sattar S, Zaorsky N, Blitzer G J Clin Invest. 2024; 134(17).

PMID: 39225092 PMC: 11364403. DOI: 10.1172/JCI182661.


A single dose of radiation elicits comparable acute salivary gland injury to fractionated radiation.

Johnson A, Elder S, McKendrick J, Hegarty L, Mercer E, Emmerson E Dis Model Mech. 2024; 17(8).

PMID: 39086326 PMC: 11361643. DOI: 10.1242/dmm.050733.


Chronic Phenotypes Underlying Radiation-Induced Salivary Gland Dysfunction.

Gunning J, Limesand K J Dent Res. 2024; 103(8):778-786.

PMID: 38808518 PMC: 11457961. DOI: 10.1177/00220345241252396.


References
1.
Dhanisha S, Guruvayoorappan C, Drishya S, Abeesh P . Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Crit Rev Oncol Hematol. 2018; 122:98-122. DOI: 10.1016/j.critrevonc.2017.12.006. View

2.
van der Reijden W, van der Kwaak H, Vissink A, Veerman E, Amerongen A . Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome. Arthritis Rheum. 1996; 39(1):57-63. DOI: 10.1002/art.1780390108. View

3.
Bodnar R . Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer. Adv Wound Care (New Rochelle). 2014; 2(1):24-29. PMC: 3840479. DOI: 10.1089/wound.2011.0326. View

4.
Takehara S, Yanagishita M, Podyma-Inoue K, Kawaguchi Y . Degradation of MUC7 and MUC5B in human saliva. PLoS One. 2013; 8(7):e69059. PMC: 3715446. DOI: 10.1371/journal.pone.0069059. View

5.
Simmons N . Epithelial cell volume regulation in hypotonic fluids: studies using a model tissue culture renal epithelial cell system. Q J Exp Physiol. 1984; 69(1):83-95. DOI: 10.1113/expphysiol.1984.sp002798. View